ProMIS Neurosciences Inc’s recent filing unveils that its Chief Scientific Officer Cashman Neil acquired Company’s shares for reported $14595.0 on Feb 10 ’25. In the deal valued at $0.97 per share,15,000 shares were bought. As a result of this transaction, Cashman Neil now holds 16,617 shares worth roughly $12795.09.
Then, Shafmaster Madge K. bought 70,000 shares, generating $91,028 in total proceeds. Upon buying the shares at $1.30, the Director now owns 208,333 shares.
Before that, Shafmaster Madge K. bought 70,000 shares. ProMIS Neurosciences Inc shares valued at $89,656 were divested by the Director at a price of $1.28 per share. As a result of the transaction, Shafmaster Madge K. now holds 138,333 shares, worth roughly $0.11 million.
Price Performance Review of PMN
On Friday, ProMIS Neurosciences Inc [NASDAQ:PMN] saw its stock fall -0.60% to $0.77. Over the last five days, the stock has lost -22.30%. ProMIS Neurosciences Inc shares have fallen nearly -44.08% since the year began. Nevertheless, the stocks have fallen -19.13% over the past one year. While a 52-week high of $1.59 was reached on 07/21/25, a 52-week low of $0.38 was recorded on 07/08/25.
Levels Of Support And Resistance For PMN Stock
The 24-hour chart illustrates a support level at 0.7126, which if violated will result in even more drops to 0.6587. On the upside, there is a resistance level at 0.8078. A further resistance level may holdings at 0.8491.
How much short interest is there in ProMIS Neurosciences Inc?
A steep rise in short interest was recorded in ProMIS Neurosciences Inc stocks on 2025-07-15, growing by 1.63 million shares to a total of 1.77 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 0.14 million shares. There was a rise of 92.0%, which implies that there is a positive sentiment for the stock.